loader image
The Science Foundation Ireland Research Centre for Pharmaceuticals
SSPC is a world-leading hub of Irish research expertise developing innovative technologies to address key challenges facing the pharmaceutical and biopharmaceutical industry. Our in-depth scientific and engineering research expertise aids companies who need tailored solutions to their bespoke challenges.


Our world-leading research programme covers the full scope of pharmaceutical R&D with the exception of the discovery of new chemical entities under five research themes: Molecules, Materials, Medicines, Manufacturing and Modelling.


There is a real opportunity for Ireland to grow the volume of high value jobs in the pharmaceutical sector. SSPC offers a unique proposition through its industry placement programme and 60% of SSPC graduates go on to be employed in industry both nationally and globally.


 SSPC are developing innovative technologies to address key challenges facing the pharmaceutical and biopharmaceutical industry. We delivery industry-relevant technical solutions, resulting in job growth and retention within the sector.

Latest News

Join SSPC's Alumni Group

SSPC alumni can be found all over the world, no matter how long you were part of our Centre, we want to connect and would love to hear from you.


SSPC’s world-leading Research Programme

Our unique and innovative culture of collaboration is helping the global pharmaceutical and biopharmaceutical industry to develop more environmentally sustainable methods for drug manufacturing; to increase the range of medicines available to the public and to reduce drug manufacturing costs. SSPC’s advanced research programme extends from Molecule, Materials and Medicine into the Manufacturing and Modelling space.

These themes focus on developing new methodologies for the asymmetric synthesis of APIs, molecules & methods for automated & in-flow generation of targeted drug hybrids & new therapeutic agents.

Advancing the understanding of single-component crystalline materials (SCCMs) and, especially, multi-component crystalline materials (MCCMs) in order to enable improved orally delivered drug products.

Optimising the development, production & use of safe, effective medicines with focus on poorly soluble drugs, personalized, age appropriate medicines & rational formulation approaches with predictive performance.

Enabling a disruptive change in manufacture of drug substances & drug products, through the development & implementation of continuous manufacturing, flow chemistry & end-to-end manufacturing methodologies.

This theme will develop new techniques to design and predict behaviour in silico in order to reduce trial-and-error experimentation. Developing new transformative physical models for broad uptake in drug manufacture.